Amazon, A Small Pharmacy Player, Seeks To Dent CVS And Walgreens Medicare Share

Amazon Pharmacy is introducing new features, including caregiver support and Medicare Part D access to PillPack, to expand its reach in the potentially lucrative senior market currently dominated by CVS and Walgreens. These moves aim to capture a larger share of the prescription market, particularly among the growing population of seniors and their caregivers, as Amazon's pharmacy business currently accounts for less than 1% of the total prescription dispensing market, compared to the combined 40% held by CVS and Walgreens.

Analysis

Amazon Pharmacy is strategically expanding its services with new features, including caregiver support and Medicare Part D access to its PillPack service, to target the substantial senior healthcare market. This demographic is expanding rapidly, with over 11,000 Americans turning 65 daily and more than 50 million individuals in the U.S. acting as caregivers for aging family members. Despite these initiatives and Amazon's acquisition of PillPack seven years ago for over $750 million, its pharmacy operations currently represent a small fraction of the market. Drug Channels Institute estimates Amazon Pharmacy's 2024 revenue at less than $2 billion, accounting for just 0.3% of the total prescription dispensing market, while other studies place its overall share at less than 1%. This is in stark contrast to incumbents CVS Health and Walgreens, which together command approximately 40% of the U.S. prescription market and generated over $370 billion in combined prescription revenues last year. CVS reported filling 435 million prescriptions in the first quarter, a 4.3% year-over-year increase, and Walgreens filled over 309 million prescriptions in its most recent quarter, up 3.4%. Amazon's continued non-disclosure of specific financial or prescription volume data for its pharmacy division makes a precise assessment of its traction and profitability challenging, positioning this expansion as a long-term endeavor against deeply entrenched competitors.

Key Decisions for Investors

• For Amazon (AMZN) investors, these pharmacy initiatives represent a long-term growth opportunity in a large addressable market, though the current revenue impact is minimal and competitive pressures from established players like CVS and Walgreens are significant; monitor for concrete signs of customer adoption and any future pharmacy-specific financial disclosures.
• Investors in CVS Health (CVS) and Walgreens Boots Alliance (WBA) should acknowledge the potential for increased competition from a well-capitalized entrant like Amazon, but also recognize their current dominant market positions, extensive physical footprints, and established patient relationships which provide a substantial defensive moat; closely watch for any acceleration in market share shifts or sustained margin pressure in their pharmacy segments.
• Given Amazon Pharmacy's current small scale relative to the overall market, these new features are unlikely to cause immediate large-scale disruption, but investors should assess their potential to gradually capture niche segments, particularly among tech-savvy seniors and caregivers, and evaluate the execution over the medium term.